About Kestra Medical Technologies Ltd
- Industry: Health Care
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
Frequently Asked Questions
What is the 52-week range for KMTS?
The 52-week high is $30 and the 52-week low is $17.34.
What is the P/E ratio for KMTS?
The P/E ratio data is currently unavailable.
What is the dividend yield for KMTS?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -64.18%.
What is the Net Profit Margin?
The Net Profit Margin (TTM) is -140.43%.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 4.66.
Analyst Recommendation Trends
Wall Street analyst consensus for KMTS over the last few months:
Latest KMTS News
Kestra Medical Technologies Earns Five-Star Rating on Newsweek’s List of America’s Greatest Mid-Market Companies
KIRKLAND, Wash., Oct. 01, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, has earned a five-star rating on Newsweek’s list of America’s Greatest Mid-Market Companies 2026. Only 30 of the 100 honorees earned five stars, and Kestra was the only company in the Medical Equipment Manufacturing category to receive that rating. “In less than a decade, our team brought the ASSURE® WCD to market and built a rapid
Kestra Medical Technologies (KMTS) Could Be 17% Undervalued Following Raised Revenue Outlook
Why Kestra Medical Technologies Stock Is Back In Focus Kestra Medical Technologies (KMTS) has drawn fresh attention after first quarter results showed sales of US$30.97 million and a net loss of US$44.09 million, alongside a higher fiscal 2027 revenue outlook. The recent update has landed after a strong run in Kestra Medical Technologies’ share price, with a 90 day share price return of 19.72%. This comes even though the 30 day share price return is down 8.23% and the 1 year total shareholder...
Kestra Medical (KMTS) Raises Outlook. Can Better Reimbursement Support Scale?
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) reported on September 14 that fiscal first-quarter 2027 revenue increased 60% to $31.0 million. Gross margin reached 56.5%, up from 45.7%, for the quarter ended July 31, 2026. Management raised fiscal 2027 revenue guidance to $141 million from $137 million, implying 48% annual growth. The outlook strengthens the commercial story, […]
Kestra Medical: Strong Scaling Story, But Profitability Still On The Horizon
Kestra Medical Technologies is transitioning into a high-growth, high-quality medtech platform with 60% YoY revenue growth. Read why KMTS stock is a hold.
KESTRA MEDICAL TECHNOLOGIES, LTD. Q1 2027 Earnings Call Summary
Moby summary of KESTRA MEDICAL TECHNOLOGIES, LTD.'s Q1 2027 earnings call
Kestra Medical Technologies Posts Mixed Q1 Results, Joins Enova International, Dave and Buster's And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session
Kestra Medical fell 8.6% after missing earnings estimates despite beating sales forecasts; several other stocks also declined premarket.
Kestra Medical Technologies Ltd (KMTS) (Q1 2027) Earnings Call Highlights: Revenue Jumps 60% as ...
Kestra Medical Technologies Ltd (KMTS) posted 60% revenue growth, a record 11th straight quarter of gross margin expansion, and raised its FY27 outlook on surging in-network mix and faster rep ramps.
BTIG Reiterates Buy on Kestra Medical Techs, Maintains $32 Price Target
BTIG analyst Marie Thibault reiterates Kestra Medical Techs (NASDAQ:KMTS) with a Buy and maintains $32 price target.
Why Veea Shares Are Trading Higher By 58%; Here Are 20 Stocks Moving Premarket
Veea shares surged 58% premarket on a NovaGen merger plan and $10M GeoNova investment, while other stocks posted notable gains and losses.
Kestra Medical Technologies, Ltd. (KMTS) Q1 2027 Earnings Call Transcript
Kestra Medical Technologies, Ltd. (KMTS) Q1 2027 Earnings Call September 14, 2026 4:30 PM EDTCompany ParticipantsNeil Bhalodkar - Vice President of Investor...
Kestra Medical Technologies Q1 Earnings Call Highlights
Kestra Medical Technologies (NASDAQ:KMTS) reported first-quarter fiscal 2027 revenue of $31 million, with President and Chief Executive Officer Brian Webster saying revenue rose 60% from a year earlier and advanced sequentially from the fourth quarter. The company raised its full-year revenue outloo
Kestra Medical Technologies, Ltd. (KMTS) Reports Q1 Loss, Tops Revenue Estimates
Kestra Medical Technologies, Ltd. (KMTS) delivered earnings and revenue surprises of -22.95% and +6.66%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?
What's going on in today's after hours session
After the conclusion of the US market's regular session on Monday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.
Kestra Medical Technologies Reports First Quarter Fiscal 2027 Financial Results
KIRKLAND, Wash., Sept. 14, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, today reported financial results for the first quarter of fiscal year 2027, which ended July 31, 2026. Financial Highlights Generated revenue of $31.0 million in F1Q27, an increase of 60% compared to the prior year period.Expanded gross margin to 56.5% in F1Q27 compared to 45.7% in the prior year period.Increased FY27 revenue guid
Transcript: Kestra Medical Techs Q1 2027 Earnings Conference Call
Kestra Medical Techs (NASDAQ:KMTS) released first-quarter financial results and hosted an earnings call on Monday. Read the complete transcript below. Benzinga APIs provide real-time access to earnings call transcripts
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Circle8 Group (NASDAQ:CIRC) stock moved upwards by 14.6% to $0.57 during Monday's after-market session. The company's market cap stands at $50.2 million. Eocene (NASDAQ:EOCN) shares rose 10.65% to
Kestra Medical Techs Q1 EPS $(0.75) Misses $(0.62) Estimate, Sales $30.971M Beat $29.007M Estimate
Kestra Medical Techs (NASDAQ:KMTS) reported quarterly losses of $(0.75) per share which missed the analyst consensus estimate of $(0.62) by 20.97 percent. This is a 50 percent decrease over losses of $(0.50) per share
Kestra Medical Techs Raises FY2027 Sales Guidance from $137.000M to $141.000M vs $137.023M Est
Kestra Medical Techs (NASDAQ:KMTS) raises FY2027 sales outlook from $137.000 million to $141.000 million vs $137.023 million estimate.
AI Infrastructure Stock Forgent Power, Cardiovascular Play Kestra In Earnings Spotlight
Forgent stock had a successful IPO, but the AI infrastructure stock is down sharply ahead of its upcoming earnings report.
Kestra Likely To Report Q1 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
Kestra Medical Technologies will report its first earnings Sept. 14, with analysts expecting a $0.62 EPS loss and $29.01M revenue.
Kestra Names Daniel Finney Vice President of Research & Development
KIRKLAND, Wash., Sept. 10, 2026 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a leading wearable medical device and digital healthcare company, announced today that Daniel Finney has been named Vice President of Research & Development and appointed to the company’s executive leadership team. “Research and development is central to advancing our mission and expanding the role of wearable protection for at-risk patients during critical periods of recovery,” said Brian Webst
Analysts Estimate Kestra Medical Technologies, Ltd. (KMTS) to Report a Decline in Earnings: What to Look Out for
Kestra Medical Technologies, Ltd. (KMTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-30 | COHEN RAYMOND W | -3,330 | $29.2805 | $97,504 |
| 2026-09-21 | Kwo Elizabeth | -4,010 | $24.2563 | $97,268 |
| 2026-09-09 | Hanley Conor | +7,217 | - | - |
| 2026-09-09 | Reilly Kevin C | +7,217 | - | - |
| 2026-09-09 | Kwo Elizabeth | +7,217 | - | - |
| 2026-09-09 | Ladone Mary Kay | +7,217 | - | - |
| 2026-09-09 | Schwartz Jeffrey Lawrence | +7,217 | - | - |
| 2026-09-09 | COHEN RAYMOND W | +7,217 | - | - |
| 2026-09-08 | Hanley Conor | -5,694 | $25.2509 | $143,779 |
| 2026-09-08 | Reilly Kevin C | -2,932 | $25.1287 | $73,677 |
| 2026-09-08 | Ladone Mary Kay | -3,908 | $25.1956 | $98,464 |
| 2026-09-08 | Schwartz Jeffrey Lawrence | -3,890 | $25.178 | $97,942 |
| 2026-08-17 | Webster Brian Daniel | -15,000 | $27.4787 | $412,181 |
| 2026-08-07 | Mahboob Vaseem | -500 | $26.33 | $13,165 |
| 2026-08-07 | Mahboob Vaseem | -25,787 | $25.8742 | $667,218 |
| 2026-08-04 | Umberger Traci S | -3,580 | $24.0428 | $86,073 |
| 2026-08-04 | Webster Brian Daniel | -442 | $25.9835 | $11,485 |
| 2026-08-04 | Webster Brian Daniel | -2,833 | $25.1635 | $71,288 |
| 2026-08-04 | Webster Brian Daniel | -48,625 | $24.4692 | $1,189,815 |
| 2026-08-04 | Mahboob Vaseem | -3,915 | $25.1696 | $98,539 |
| 2026-08-04 | Mahboob Vaseem | -3,080 | $24.057 | $74,096 |
| 2026-08-04 | Ford Alfred J Jr | -6,275 | $24.0862 | $151,141 |
| 2026-08-03 | Umberger Traci S | -7,590 | $23.8553 | $181,062 |
| 2026-08-03 | Webster Brian Daniel | -13,017 | $23.9244 | $311,424 |
| 2026-08-03 | Moran Timothy P. | -2,380 | $23.7611 | $56,551 |
| 2026-08-03 | Mahboob Vaseem | -5,391 | $23.8012 | $128,312 |
| 2026-08-03 | Ford Alfred J Jr | -13,015 | $23.9046 | $311,118 |
| 2026-07-31 | Umberger Traci S | -8,752 | $22.6048 | $197,837 |
| 2026-07-31 | Webster Brian Daniel | -8,948 | $22.6039 | $202,260 |
| 2026-07-31 | Moran Timothy P. | -8,759 | $22.6054 | $198,001 |
| 2026-07-31 | Mahboob Vaseem | -8,817 | $22.6091 | $199,344 |
| 2026-07-31 | Ford Alfred J Jr | -8,681 | $22.6108 | $196,284 |
| 2026-07-30 | Umberger Traci S | -5,887 | $22.7437 | $133,892 |
| 2026-07-30 | Webster Brian Daniel | -7,857 | $22.7225 | $178,531 |
| 2026-07-30 | Moran Timothy P. | -4,117 | $22.7735 | $93,758 |
| 2026-07-30 | Mahboob Vaseem | -3,980 | $22.7539 | $90,561 |
| 2026-07-30 | Ford Alfred J Jr | -5,936 | $22.7629 | $135,121 |
| 2026-07-16 | Moran Timothy P. | +39,113 | - | - |
| 2026-07-15 | Umberger Traci S | +58,832 | - | - |
| 2026-07-15 | Webster Brian Daniel | -3,000 | $23.9983 | $71,995 |
| 2026-07-15 | Webster Brian Daniel | -784 | $22.6333 | $17,745 |
| 2026-07-15 | Webster Brian Daniel | -11,216 | $22.0105 | $246,870 |
| 2026-07-15 | Webster Brian Daniel | +176,470 | - | - |
| 2026-07-15 | Mahboob Vaseem | +44,118 | - | - |
| 2026-07-15 | Ford Alfred J Jr | +58,832 | - | - |
| 2026-06-30 | Umberger Traci S | +942 | $21.55 | $20,300 |
| 2026-06-30 | Moran Timothy P. | +227 | $21.55 | $4,892 |
| 2026-06-03 | Umberger Traci S | +25,227 | - | - |
| 2026-06-03 | Webster Brian Daniel | +75,681 | - | - |
| 2026-06-03 | Moran Timothy P. | +22,704 | - | - |
| 2026-06-03 | Mahboob Vaseem | +25,227 | - | - |
| 2026-06-03 | Ford Alfred J Jr | +25,227 | - | - |
| 2026-05-15 | Webster Brian Daniel | -6,845 | $21.4635 | $146,918 |
| 2026-05-15 | Webster Brian Daniel | -8,155 | $20.5287 | $167,412 |
| 2026-04-15 | Webster Brian Daniel | -15,000 | $20.0447 | $300,671 |
| 2026-03-26 | COHEN RAYMOND W | +10,000 | $19.98 | $199,800 |
| 2026-03-17 | Webster Brian Daniel | -15,000 | $20.2749 | $304,124 |
| 2026-03-11 | Reilly Kevin C | +8,300 | - | - |
| 2026-02-17 | Webster Brian Daniel | -93 | $27.1789 | $2,528 |
| 2026-02-17 | Webster Brian Daniel | -3,272 | $26.2947 | $86,036 |
| 2026-02-17 | Webster Brian Daniel | -11,635 | $25.3937 | $295,456 |
| 2026-01-15 | Webster Brian Daniel | -15,000 | $22.8016 | $342,024 |
| 2025-12-29 | Umberger Traci S | -10,500 | $26.6858 | $280,201 |
| 2025-12-29 | Webster Brian Daniel | -15,000 | $26.5898 | $398,847 |
| 2025-12-03 | Moran Timothy P. | +19,557 | - | - |